CRANBURY, N.J., Sept. 30 /PRNewswire/ -- Amicus Therapeutics (Nasdaq: FOLD) announced today that the Company's Chief Operating Officer, Matthew R. Patterson will be presenting a corporate overview at the BIO Investor Forum being held in San Francisco, CA. Mr. Patterson's presentation is scheduled to begin at 1:30 p.m. (PT) on Tuesday, October 5, 2010.
Individuals can listen to a live webcast of the presentation by logging on to the Investors section of the Amicus Therapeutics' Web site, http://www.amicustherapeutics.com. Participants should allow approximately five to ten minutes prior to the presentation's start time to visit the site and download any streaming media software needed to listen to the Internet webcast. A replay of the webcast will also be available on the Company's Web site for 30 days.
About Amicus Therapeutics
Amicus Therapeutics is a biopharmaceutical company focused on developing treatments for rare diseases. The Company is developing orally-administered, small molecule drugs called pharmacological chaperones, a novel, first-in-class approach to treating a broad range of diseases including lysosomal storage disorders and CNS diseases. Amicus' lead program is in Phase 3 for the treatment of Fabry disease.FOLD –G SOURCE Amicus Therapeutics